Haoxi Health Technology Limited
HAO
$0.98
-$0.03-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.42M | 4.42M | 11.98M | 11.98M | 12.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.42M | 4.42M | 11.98M | 11.98M | 12.51M |
| Cost of Revenue | 4.20M | 4.20M | 11.74M | 11.74M | 11.73M |
| Gross Profit | 223.70K | 223.70K | 240.20K | 240.20K | 774.50K |
| SG&A Expenses | 1.15M | 1.15M | 270.10K | 270.10K | 300.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.36M | 5.36M | 12.04M | 12.04M | 12.06M |
| Operating Income | -936.30K | -936.30K | -63.70K | -63.70K | 449.40K |
| Income Before Tax | 2.07M | 2.07M | 1.00K | 1.00K | 467.50K |
| Income Tax Expenses | 18.10K | 18.10K | 117.30K | 117.30K | 201.80K |
| Earnings from Continuing Operations | 2.05M | 2.05M | -116.30K | -116.30K | 265.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.05M | 2.05M | -116.30K | -116.30K | 265.70K |
| EBIT | -936.30K | -936.30K | -63.70K | -63.70K | 449.40K |
| EBITDA | -793.70K | -793.70K | -58.90K | -58.90K | 452.10K |
| EPS Basic | 0.72 | 0.72 | -0.06 | -0.06 | 0.21 |
| Normalized Basic EPS | 0.45 | 0.45 | 0.00 | 0.00 | 0.23 |
| EPS Diluted | 0.57 | 0.57 | -0.06 | -0.06 | 0.21 |
| Normalized Diluted EPS | 0.43 | 0.43 | 0.00 | 0.00 | 0.23 |
| Average Basic Shares Outstanding | 2.85M | 2.85M | 1.81M | 1.81M | 1.27M |
| Average Diluted Shares Outstanding | 2.98M | 2.98M | 1.81M | 1.81M | 1.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |